You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 123 No. 9, September 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Association of Progressive Systemic Scleroderma to Several HLA-B and HLA-DR Alleles

Christoph Luderschmidt, MD; Siegfried Scholz, MD; Elisabeth Mehlhaff, MD; Gerhard König, MD; Ekkehard Albert, MD

Arch Dermatol. 1987;123(9):1188-1191.


Abstract



• The HLA-A, B, C, and DR loci of 136 patients with progressive systemic scleroderma have been determined. The patients were classified according to the extent of their skin affection and into groups with or without immunologic and inflammatory signs of the disease. The antigens of the A locus did not show any significant deviations in frequency of occurrence. An increase of HLA-B8 and HLA-DR3 was only proved in the male patient group. Furthermore, in the HLA-DR gene locus, an increase in frequency of HLA-DR1, 2, 3, and 5 could be found. However, in the total set of patients, only the correlation of HLA-DR5 with progressive systemic scleroderma reached significance. Patients suffering from the CREST (calcinosis, Raynaud's phenomenon, esophagus, sclerodactyly, and telangiectasia) syndrome showed an increase of HLA-DR1. Patients with inflammatory signs of the scleroderma showed an accumulation of HLA-DR2. Several HLA-linked genes control the susceptibility to scleroderma.

(Arch Dermatol 1987;123:1188-1191)



Author Affiliations



From the Dermatological Clinic and Polyclinic of the Rheinische Friedrich-Wilhelms University, Bonn, West Germany (Dr Luderschmidt); the Laboratory for Immunogenetics of the Polyclinic of the Ludwig-Maximilian University (Drs Scholz, Mehlhaff, and Albert), and the Pneumonological Department of the Medical Clinic I Klinikum Grosshadern of the Ludwig-Maximilian University (Dr König), Munich.


Footnotes



Accepted for publication Feb 20, 1987.

Reprint requests to Residenzstrasse 27, D-8000 Munich, West Germany (Dr Luderschmidt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women
Loubiere et al.
Rheumatology (Oxford) 2005;44:318-322.
ABSTRACT | FULL TEXT  

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele
Vlachoyiannopoulos et al.
Ann Rheum Dis 2000;59:359-367.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.